logo

For the Inventor, By the Inventor

Yardley, PA, United States of America

Berthold Richard Vogt

This inventor holds 24 USPTO granted patents, primarily in Isoquinoline Chemistry. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Berthold Richard Vogt. Retrieved from https://idiyas.com/inventor/berthold-richard-vogt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 141(Granted Patents)


Company Filing History:

goldMedal24 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1976-1979

Loading Chart...
Areas of Expertise:
Isoquinoline
Tetrahydro
Piperidinyl
Diones
Phenyl
Cyclohepta
Triazolo
Oxazepin
Dihydro
Substituted
Pyrazolo
Hetero-Cyclic
24 patents (USPTO):Explore Patents
1. 4180579 - 2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones (1979-12-25),
2. 4179564 - 1,5,6,11-Tetrahydro[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridine (1979-12-18),
3. 4170651 - 2-Substituted-1H-benz-[de]-isoquinoline-1,3(2H)-diones (1979-10-09),
4. 4127715 - Various (1978-11-28),
5. 4115555 - 2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones (1978-09-19),
6. 4111940 - 1,5,6,11-Tetrahydro[5,6]cyclohepta-[1,2,-b]pyrazolo[4,3-e]pyridine (1978-09-05),
7. 4087433 - 1,5,10,11-Tetrahydrobenzo[4,5]-cyclohepta[1,2-b]pyrazolo[4,3-e]pyridines (1978-05-02),
8. 4077958 - 2-[(Substituted (1978-03-07),
9. 4070465 - Various 2-(substituted piperazinyl)-1H-benz [de]isoquinoline-1,3 (2H) (1978-01-24),
10. 4062953 - Various 2-substituted-1H-benz[de]isoquinoline-1,3(2H)-diones (1977-12-13),
11. 4051246 - 2-Substituted-1H-benz(de)-isoquinoline-1,3-(2H)-diones (1977-09-27),
12. 4033970 - Various 1,5,10,11-tetrahydrobenzo [4,5]-cyclohepta (1977-07-05),
13. 4020064 - 3-[Substituted-2-(methylamino) phenyl]-4-[2-oxo-2-(hetero-cyclic) (1977-04-26),
14. 4007191 - 2-(Piperidinyl or (1977-02-08),
15. 4002639 - 2-(Substituted phenyl)-dibenz[b,f][1,2,4]triazolo-[4,3-d][1,4]oxazepin (1977-01-11),

Title: **Berthold Richard Vogt: Innovator in Anti-Inflammatory Compounds**

Introduction

Berthold Richard Vogt, based in Yardley, PA, is a prominent inventor recognized for his significant contributions in the field of medicinal chemistry. With a remarkable portfolio of 24 patents, he has been instrumental in developing compounds that exhibit useful anti-inflammatory and psychotropic activities.

Latest Patents

Among Vogt’s recent innovations are two notable patents. The first patent focuses on **2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones**, presenting compounds with various R groups, including hydrogen, halogen, and lower alkyls. These compounds have shown promising anti-inflammatory properties. The second patent pertains to **1,5,6,11-Tetrahydro[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridine**, which details derivatives that possess both anti-inflammatory and psychotropic activity.

Career Highlights

Vogt is affiliated with E.R. Squibb & Sons, Inc., where he has contributed extensively to pharmaceutical innovations. His work has gained recognition not only for its scientific merit but also for its potential impact on therapeutic applications.

Collaborations

During his career, Vogt has collaborated with esteemed colleagues such as Peter C. Wade and Hans Hoehn. These partnerships have fostered an environment of innovation, leading to advancements in drug development and formulation.

Conclusion

Berthold Richard Vogt continues to play a pivotal role in the field of medicinal chemistry. His dedication to innovation and collaboration has positioned him as a vital contributor to the advancements in anti-inflammatory compounds, reflecting the importance of research and development in enhancing therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…